IRIDEX (NASDAQ:IRIX) Posts Quarterly Earnings Results

IRIDEX (NASDAQ:IRIX) posted its quarterly earnings data on Tuesday. The medical equipment provider reported ($0.12) earnings per share for the quarter, Zacks reports. IRIDEX had a negative return on equity of 163.45% and a negative net margin of 22.79%. The business had revenue of $11.58 million during the quarter. During the same period last year, the firm earned ($0.11) earnings per share.

IRIDEX Stock Performance

Shares of NASDAQ IRIX traded down $0.04 during mid-day trading on Thursday, hitting $1.85. The stock had a trading volume of 52,431 shares, compared to its average volume of 31,245. The firm has a market cap of $30.54 million, a PE ratio of -2.82 and a beta of 0.80. The company has a 50 day moving average of $1.68 and a two-hundred day moving average of $2.03. IRIDEX has a twelve month low of $1.27 and a twelve month high of $3.65.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of IRIDEX in a research report on Saturday, November 9th. They issued a “hold” rating for the company.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.